Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1160
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2025-03-27T09:07:20Z-
dc.date.available2025-03-27T09:07:20Z-
dc.date.issued2025-03-23-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/1160-
dc.description.abstractModified surface hemoglobin is produced by attaching large molecules, such as polyethylene glycol, to the surface groups of lysine. This modification increases the viscosity and oncotic pressure of the solution [4]. These solutions can moderately constrict blood vessels. Due to the small size of the hemoglobin molecules, they can pass through small vessels and saturate areas with oxygen that are inaccessible to erythrocytes. This makes it useful for treating patients with strokes, as well as increasing the sensitivity of tumor cells to radiation or chemotherapy. Additionally, the vasopressor effects can be used to treat hypotension after septic shock. This type of hemoglobin also has a low frequency of antibody production.en_US
dc.language.isoenen_US
dc.publisherInnovative developments and research in educationen_US
dc.relation.ispartofseriespart;37-
dc.subjectHemoglobin,hemosomes,liposomes,modifications,Polyethylene Glycol, COVID-19,sepsisen_US
dc.titleModified surface hemoglobin (PEG HB, PHP, HAEMOSPAN)en_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
Modified surface hemoglobin (PEG HB, PHP, HAEMOSPAN),.pdf856.89 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.